Colgate-Palmolive (NYSE:CL) SVP John J. Huston sold 14,000 shares of Colgate-Palmolive stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $69.44, for a total value of $972,160.00. Following the transaction, the senior vice president now owns 100,508 shares in the company, valued at $6,979,275.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Shares of Colgate-Palmolive (NYSE:CL) traded up $0.11 during trading on Tuesday, hitting $70.30. The stock had a trading volume of 3,373,435 shares, compared to its average volume of 4,439,941. The company has a market capitalization of $61,510.00, a price-to-earnings ratio of 30.83, a price-to-earnings-growth ratio of 2.58 and a beta of 0.75. Colgate-Palmolive has a 12 month low of $67.19 and a 12 month high of $77.91. The company has a current ratio of 0.47, a quick ratio of 0.34 and a debt-to-equity ratio of 24.42.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 26th. The company reported $0.75 EPS for the quarter, meeting analysts’ consensus estimates of $0.75. The company had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.75 earnings per share. analysts expect that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.
Several research analysts have weighed in on the company. Citigroup lifted their target price on Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a report on Tuesday, January 30th. BNP Paribas lowered Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Jefferies Group reiterated a “hold” rating and set a $79.00 target price on shares of Colgate-Palmolive in a report on Friday, January 26th. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a report on Tuesday, January 16th. Finally, Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target on the stock in a report on Tuesday, December 19th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $77.71.
Large investors have recently added to or reduced their stakes in the stock. Jacobi Capital Management LLC increased its position in shares of Colgate-Palmolive by 125.5% in the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after acquiring an additional 803 shares during the last quarter. Krilogy Financial LLC increased its position in shares of Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after acquiring an additional 289 shares during the last quarter. Calton & Associates Inc. acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $126,000. Captrust Financial Advisors acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at about $122,000. Finally, AlphaMark Advisors LLC increased its position in shares of Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after acquiring an additional 25 shares during the last quarter. 72.85% of the stock is currently owned by institutional investors and hedge funds.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.